Sanofi India Limited

Generic Name: Voglibose 0.3mg

This product has been discontinued.

Medicine Information

About Vogsite MD 0.3 mg Tablet: 

Vogsite MD 0.3 mg Tablet is an antidiabetic class of medication prescribed for the treatment of type 2 diabetes mellitus.

Each uncoated mouth dissolving Vogsite MD 0.3 mg Tablet contains Voglibose 0.3 mg.

Voglibose is an alpha-glucosidase inhibitor that works by lowering post-prandial blood glucose levels in people with type 2 diabetes mellitus.

Use of Vogsite MD 0.3 mg Tablet:

Vogsite MD 0.3 mg Tablet is an oral antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes (non-insulin dependent diabetes mellitus, NIDDM).

Usage Direction of Vogsite MD 0.3 mg Tablet:

  • Vogsite MD 0.3 mg Tablet is intended for oral use only, in a dose and direction as prescribed by the physician.
  • For administration, Vogsite MD 0.3 mg Tablet is to be kept in the mouth until it dissolves completely. No need to swallow.
  • Do not skip or stop the medicine without the physician’s advice.
  • Do not exceed the stated recommended daily dosage.

Precaution & Related information of Vogsite MD 0.3 mg Tablet:

  • If hypersensitive or allergic to Vogsite MD 0.3 mg Tablet, inform the physician immediately.
  • If found any other complications, inform the physician immediately.
  • The physician should be well informed when concomitant consumption of this tablet with any other medicines or supplements.
  • Consult with the physician during pregnancy & lactation.
  • Keep the medicine out of reach of children.

Storage condition of Vogsite MD 0.3 mg Tablet:

  • Store in a cool, dry & dark place.